AzTrials
AzTrials

Radius Fracture DistalSLA-VerNCT03468023

Short vs Long Arm Cast for Distal Radius Fractures: the Verona Trial

A study testing Short arm cast and Long arm cast in people with Radius Fracture Distal, run by Azienda Ospedaliera Universitaria Integrata Verona at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study prospectively compares the performance of an above-elbow cast (long arm cast) and a below-elbow cast (short arm cast) to maintain reduction in conservatively managed distal radius fractures. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Radius Fracture Distal
What is being tested?
Short arm cast and Long arm cast
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
353 participants
Where
1 siteItaly
Study dates
15 Mar 2017to 28 Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosis of distal radius fracture
  • Indication to conservative treatment
  • Need for manipulation to reduce fracture

Who cannot join

  • Open fractures
  • Existence of any skin lesion or wound that would impair cast treatment
  • Neurovascular deficits
  • Bilateral fractures
  • Association with any other fracture of the homolateral arm

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Ospedale Civile Maggiore Borgo Trento

    Verona, 37126

Other trials in Italy

About this study

Official title: Short vs Long Arm Cast for Distal Radius Fractures: the Verona Trial. Randomized Clinical Trial to Assess the Efficacy of Short Arm Cast Versus Long Arm Cast in Conservative Management of Distal Radius Fractures

This study prospectively compares the performance of an above-elbow cast (long arm cast) and a below-elbow cast (short arm cast) to maintain reduction in conservatively managed distal radius fractures.

Read the detailed description

The choice of cast length in conservative management of distal radius fractures still represents a much debated controversy. Classic teaching was to immobilize the elbow to reduce risk of secondary displacement; however, short arm casts are felt to be equally effective with less complications and higher patient comfort. There is currently no conclusive evidence for or against immobilization of the elbow in patients treated with cast immobilization.

Being tested
Short arm cast, Long arm cast
Keywords
Cast treatment, above-elbow cast, below-elbow cast, long arm cast, short arm cast
Medical subject headings
Wrist Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Short arm castProcedure or surgery

    Also called below-elbow cast, antebrachio-metacarpal cast

    Application of a below-elbow cast

  • Long arm castProcedure or surgery

    Also called above-elbow cast, brachio-metacarpal cast

    Application of an above-elbow cast

Study groups in NCT03468023
Study groupRoleWhat they receive
Short arm castExperimentalPatient treated with below-elbow cast
Receives: Procedure: Short arm cast
Long arm castActive comparatorPatients treated with above-elbow cast
Receives: Procedure: Long arm cast

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Secondary displacement ratio

    Percentage of fractures that displace during treatment as subjectively assessed on radiographs by investigators.

    Measured: 35 days

  2. Variation of radial length

    Difference between radial length values as objectively measured on postreduction radiographs and endtreatment radiographs.

    Measured: 35 days

  3. Variation of radial inclination

    Difference between radial inclination values as objectively measured on postreduction radiographs and endtreatment radiographs.

    Measured: 35 days

  4. Variation of volar tilt

    Difference between volar tilt vaues as objectively measured on postreduction radiographs and endtreatment radiographs.

    Measured: 35 days

Secondary outcomes (3)
  1. Post-treatment elbow range of motion (ROM)

    Degrees of extension, flexion, pronation and supination of the elbow measured at the end of the treatment.

    Measured: 35 days

  2. DASH score

    Disability of Arm, Shoulder and Hand score measured at the end of the treatment relating to patient's comfort during treatment.

    Measured: 35 days

  3. SF-12

    Short Form 12 health questionnaire administered at the end of the treatment relating to patient's quality of life during treatment.

    Measured: 35 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Mar 2018
  2. Study start15 Mar 2017
  3. Primary completion13 Feb 2020
  4. Study completion28 Mar 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Non-inferiority trial aimed at comparing the non inferiority of a short arm cast (below elbow cast) as opposed to a long arm cast (below elbow cast) in terms of fracture reduction maintenance ratio. The sample size was selected as the highest required to test all non-inferiority thresholds and considering a drop-out percentage of 15%. Continuous values of all radiological parameters were used in order to keep results objective and reproducible. At the end of recruitment observed drop-out percentage was 26%.
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
353 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03468023
Sponsor's protocol ID
1165CESC
Other IDs
1166CESC
Acronym
SLA-Ver
Status last verified
Sep 2020
First submitted
11 Mar 2018
Last updated
29 Sep 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Dib G, Maluta T, Cengarle M, Bernasconi A, Marconato G, Corain M, Magnan B. Short arm cast is as effective as long arm cast in maintaining distal radius fracture reduction: Results of the SLA-VER noninferiority trial. World J Orthop. 2022 Sep 18;13(9):802-811. doi: 10.5312/wjo.v13.i9.802. eCollection 2022 Sep 18.

    PubMed 36189333

Questions about this trial

What is this clinical trial studying?

A study testing Short arm cast and Long arm cast in people with Radius Fracture Distal, run by Azienda Ospedaliera Universitaria Integrata Verona at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Secondary displacement ratio (time frame: 35 days). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03468023, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Sep 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in